Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Non-cash Items (2016 - 2025)

Bio-Techne (TECH) has 13 years of Non-cash Items data on record, last reported at $7.1 million in Q2 2025.

  • For Q2 2025, Non-cash Items fell 13.1% year-over-year to $7.1 million; the TTM value through Jun 2025 reached $7.1 million, down 13.1%, while the annual FY2025 figure was $7.1 million, 13.1% down from the prior year.
  • Non-cash Items reached $7.1 million in Q2 2025 per TECH's latest filing, down from $8.2 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $8.6 million in Q2 2023 and bottomed at $7.1 million in Q2 2021.
  • Average Non-cash Items over 5 years is $7.8 million, with a median of $7.8 million recorded in 2022.
  • Peak YoY movement for Non-cash Items: soared 351.21% in 2021, then decreased 13.1% in 2025.
  • A 5-year view of Non-cash Items shows it stood at $7.1 million in 2021, then grew by 10.49% to $7.8 million in 2022, then increased by 10.82% to $8.6 million in 2023, then fell by 5.01% to $8.2 million in 2024, then fell by 13.1% to $7.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-cash Items were $7.1 million in Q2 2025, $8.2 million in Q2 2024, and $8.6 million in Q2 2023.